Efficacy and tolerability of thiabendazole in a lipophil vehicle for cutaneous Larva migrans.
Chatel
G
G
Scolari
C
C
Gulletta
M
M
Casalini
C
C
Carosi
G
G
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000969:Antinematodal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D005260:Female; D006801:Humans; D007815:Larva Migrans / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014677:Pharmaceutical Vehicles; D011446:Prospective Studies; D013827:Thiabendazole / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000969:Antinematodal Agents; D014677:Pharmaceutical Vehicles; D013827:Thiabendazole